Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Annual Report Notification

3 Jul 2008 14:39

RNS Number : 2749Y
Celsis International PLC
03 July 2008
 



FOR release: Thursday 3 July 2008

CELSIS INTERNATIONAL PLC

("Celsis", "the Company" or "the Group")

Annual Report & Accounts

3 July 2008: Celsis International plc, the international life sciences products and laboratory services company, today announces that copies of the Company's Annual Report and Accounts 2008 have been submitted to the UK Listing Authority (UKLA) and will shortly be delivered for inspection at the UKLA Document Viewing Facility, which is situated at:

 

Financial Services Authority 

25 The North Colonnade 

London 

E14 5HS 

020 7066 1000

For further information please contact:

Celsis International plc
Tel: +44 (0) 1223 598 428
Christian Madrolle, Finance Director & Company Secretary
 
Jenny Woolway, Corporate Communications
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBXGDRUXGGGIX
Date   Source Headline
29th Jun 20235:30 pmRNSResult of AGM
5th Jun 20232:46 pmRNSPublication of Annual Report and Notice of AGM
5th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
30th May 20237:00 amRNS£7 Million Committed Credit Facility
26th May 20237:00 amRNSNotice of Results and Investor Presentation
25th May 20237:00 amRNSWest Midlands Mayor Visits Celadon’s Facility
24th May 20237:00 amRNSInaugural Supply Contract Win
29th Mar 202311:05 amRNSSecond Price Monitoring Extn
29th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20232:05 pmRNSSecond Price Monitoring Extn
17th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20233:01 pmRNSSuccessful Update to Home Office Licence
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 20234:40 pmRNSSecond Price Monitoring Extn
10th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20232:15 pmRNSNotification of transaction by PDMR
19th Jan 20237:00 amRNSChange of Website Address
16th Jan 20237:00 amRNSApproval of GMP Registration by MHRA
13th Jan 20237:00 amRNSUpdate on CFO Appointment
30th Dec 20227:00 amRNSResults of Feasibility Study
22nd Dec 20227:00 amRNSUpdate on GMP Registration by MHRA
1st Nov 20227:00 amRNSAppointment of CFO
29th Sep 20227:00 amRNSInterim Report for six months ended 30 June 2022
12th Sep 20227:00 amRNSNotice of Results
28th Jul 20227:00 amRNSAppointment of Tessera Investment Management
27th Jun 20226:15 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Update
31st May 20221:30 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFull year results
29th Apr 20227:00 amRNSFull year results
31st Mar 20228:08 amRNSHolding(s) in Company
30th Mar 20224:41 pmRNSSecond Price Monitoring Extn
30th Mar 20224:36 pmRNSPrice Monitoring Extension
29th Mar 20228:00 amRNSChange of Name
7th Oct 20099:56 amRNSHolding(s) in Company
1st Oct 20096:29 pmRNSTransfers from Treasury and Admission of Shares
30th Sep 200910:50 amRNSHolding(s) in Company
24th Sep 20097:00 amRNSClosing of the Offer
9th Sep 20094:26 pmRNSCancellation of Listing
9th Sep 200912:56 pmRNSOffer Update
4th Sep 200911:57 amRNSDirector Declaration
3rd Sep 20097:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.